SOURCE: Implant Sciences

Implant Sciences

May 16, 2011 07:00 ET

Implant Sciences Launches Bench-Top Explosives and Narcotics Trace Detector

New Product for Security, Defense, and Anti-Terrorism Applications Debuts at Force Protection Equipment Demonstration VIII

WILMINGTON, MA--(Marketwire - May 16, 2011) - In a move to further accelerate revenue growth and market penetration, Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced the launch of its new bench-top explosives and narcotics trace detector, the Quantum Sniffer™ QS-B220. Implant Sciences has already gained significant market traction with its portable explosives trace detector (ETD), the Quantum Sniffer QS-H150, which has sold over 1,300 units worldwide, totaling over $30 million in sales.

The QS-B220 is a user-friendly, low maintenance system that offers compelling economics for purchasers. It contains no radioactive materials, eliminating licensing, annual testing, and end-of-life disposal issues. A built-in automatic calibration system requires no user intervention or expensive disposables. And the QS-B220's rapid clear-down design increases operational availability and improves checkpoint throughput.

Building upon the field-tested core technology of the Quantum Sniffer QS-H150, the QS-B220 has been engineered to meet the needs of a wide range of security applications, including the requirements of the U.S. Transportation Security Administration (TSA). The system features one of the smallest footprints in the industry, making it ideal for crowded security checkpoints at airports and air cargo screening facilities. Able to detect a very wide variety of trace substances, including both narcotics and explosives, it opens new market opportunities for Implant Sciences such as prisons and border crossings.

The QS-B220 will be launched at FPED VIII, the Force Protection Equipment Demonstration, being held in Stafford Virginia, from May 17th -19th. The event, sponsored by the Department of Defense and Department of Energy, will provide Implant Sciences a venue for presenting its products and technology to the key federal, state and local decision makers in the purchase of security equipment.

Implant Sciences will sell the QS-B220 through its growing global network of 32 distributors on 6 continents.

"The QS-B220 is poised to fill a market need for a bench-top ETD that offers the same advantages as our portable QS-H150, as well as some new innovations. We anticipate that the QS-B220 will help drive increasing revenues through our expanding sales channels," stated Implant Sciences CEO, Glenn Bolduc.

Todd Silvestri, Vice President of Product Development concluded, "Implant Sciences is one of today's true innovators in trace detection. We are continuously developing new products and technologies that will help our customers increase security in a variety of applications."

About the Quantum Sniffer QS-H150
The QS-H150 Quantum Sniffer is a hand-held explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability and extremely low total cost of ownership.

About the Quantum Sniffer QS-B220
The Quantum Sniffer QS-B220 is a bench-top explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, or homemade explosives and narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    CEO
    978-752-1700
    Email Contact

    or

    Investor Contact:
    Laurel Moody
    646-810-0608

    Email Contact